2,3-dinor-thromboxane b2 and Ductus Arteriosus, Patent

2,3-dinor-thromboxane b2 has been researched along with Ductus Arteriosus, Patent in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cotton, RB; FitzGerald, GA; Kuehl, PG	1

Other Studies

1 other study(ies) available for 2,3-dinor-thromboxane b2 and Ductus Arteriosus, Patent

Article	Year
Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants. The Journal of pediatrics, 1986, Volume: 108, Issue:6 Topics: 6-Ketoprostaglandin F1 alpha; Ductus Arteriosus, Patent; Epoprostenol; Gas Chromatography-Mass Spectrometry; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Prospective Studies; Thromboxane B2	1986

Article

Year

Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants.

The Journal of pediatrics, 1986, Volume: 108, Issue:6

Topics: 6-Ketoprostaglandin F1 alpha; Ductus Arteriosus, Patent; Epoprostenol; Gas Chromatography-Mass Spectrometry; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Prospective Studies; Thromboxane B2

1986